Key clinical point: For hidradenitis suppurativa, the starting dose of infliximab should be higher than the 5 mg/kg recommended for psoriasis.
Major finding: On a 7.5 mg/kg starting dose of infliximab, average pain scores fell from 5.65 to 1.34 within 4 weeks.
Data Source: A retrospective chart review.
Disclosures: The authors report no potential conflicts of interest.
77th Annual Meeting of the Society for Investigative Dermatology